Status:
COMPLETED
Rosuvastatin ORBITAL Germany
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary objective of the study is to compare the effect of rosuvastatin therapy plus compliance initiatives and rosuvastatin therapy alone for 12 months (52 weeks) on long-term cumulative direct a...
Eligibility Criteria
Inclusion
- high cholesterol with an indication for cholesterol-lowering medication (statins)
Exclusion
- contra-indications for statin therapy
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
February 1 2004
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT00379249
Start Date
February 1 2002
End Date
February 1 2004
Last Update
March 26 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.